John Overdeck’s IO Biotech IOBT Stock Holding History

John Overdeck’s Portfolio IOBT Stock Details IOBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-30,000	Closed	-$31.5K	–	3341
2024 Q3	$31.5K	Buy	+30,000	New	+$37.8K	﹤0.01%	2997

Other funds holding IOBT

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

PBPIA

Pivotal bioVenture Partners Investment Advisor San Francisco, California $308M AUM 120.89% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

DIG

Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return

LCM

Landscape Capital Management Englewood, New Jersey $1.54B AUM 30.95% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

John Overdeck's IOBT Position: Q4 2024 in Review

John Overdeck sold out of IO Biotech (IOBT) in Q4 2024, closing a stake of 30,000 shares — an estimated $31.5K sold.

John Overdeck first reported a position in IOBT in Q3 2024 and held it in 1 quarter. The position peaked at $31.5K in Q3 2024. 27 funds tracked by Wall St. Rank hold IOBT as of Q4 2024.

John Overdeck reported no remaining IO Biotech position as of Q4 2024 after selling out during the quarter.
John Overdeck sold 30,000 IO Biotech shares in Q4 2024, an estimated $31.5K.
John Overdeck first reported a position in IO Biotech in Q3 2024 and held it in 1 quarter.
John Overdeck's IO Biotech position peaked at $31.5K in Q3 2024.
27 funds tracked by Wall St. Rank held IO Biotech as of Q4 2024.

Based on Two Sigma Investments's 13F filing for Q4 2024, filed 14 Feb 2025.